This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Remegen, Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Yuanhao Li
Introduction
Yuanhao Li is a prominent inventor based in Yantai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work has garnered attention for its potential impact on medical treatments.
Latest Patents
Yuanhao Li holds a patent for an "ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF." This patent represents a significant advancement in targeted therapy, showcasing his expertise in antibody development and drug conjugation. He has 1 patent to his name, reflecting his commitment to innovation in the medical field.
Career Highlights
Currently, Yuanhao Li is associated with Remegen, Ltd., a company known for its focus on innovative biopharmaceuticals. His role at Remegen has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes through advanced therapies.
Collaborations
Yuanhao Li collaborates with notable colleagues, including Jianmin Fang and Marie M Zhu. These partnerships enhance the research environment and foster the exchange of ideas, contributing to the advancement of their collective work in biotechnology.
Conclusion
Yuanhao Li's contributions to the field of biotechnology, particularly through his patent and work at Remegen, Ltd., highlight his role as an influential inventor. His ongoing efforts in research and development continue to pave the way for innovative medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile